CVS Health Corporation (CVS) Shares Sold by Blue Fin Capital Inc.

Blue Fin Capital Inc. lowered its holdings in CVS Health Corporation (NYSE:CVS) by 7.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,077 shares of the pharmacy operator’s stock after selling 1,650 shares during the quarter. CVS Health Corporation accounts for about 1.1% of Blue Fin Capital Inc.’s investment portfolio, making the stock its 23rd largest position. Blue Fin Capital Inc.’s holdings in CVS Health Corporation were worth $1,776,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Gemmer Asset Management LLC grew its holdings in CVS Health Corporation by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the last quarter. TB Alternative Assets Ltd. acquired a new stake in CVS Health Corporation in the 2nd quarter valued at approximately $121,000. SRS Capital Advisors Inc. grew its holdings in CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares during the last quarter. Grace & White Inc. NY acquired a new stake in CVS Health Corporation in the 2nd quarter valued at approximately $199,000. Finally, Nadler Financial Group Inc. acquired a new stake in CVS Health Corporation in the 2nd quarter valued at approximately $202,000. 81.46% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Corporation (NYSE:CVS) opened at 74.63 on Friday. The company has a market cap of $75.87 billion, a P/E ratio of 14.87 and a beta of 0.92. The company’s 50 day moving average price is $78.89 and its 200 day moving average price is $78.72. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $88.84.

CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same period in the prior year, the company earned $1.32 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts anticipate that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.68%. The ex-dividend date of this dividend is Monday, October 23rd. CVS Health Corporation’s payout ratio is presently 39.92%.

In other CVS Health Corporation news, CFO David M. Denton sold 237,078 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the completion of the sale, the chief financial officer now directly owns 141,096 shares in the company, valued at $11,238,296.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The disclosure for this sale can be found here. Insiders have sold 716,625 shares of company stock valued at $58,318,431 over the last 90 days. Corporate insiders own 0.61% of the company’s stock.

CVS has been the topic of a number of research analyst reports. BidaskClub lowered CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Loop Capital assumed coverage on CVS Health Corporation in a report on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective on the stock. Leerink Swann set a $90.00 price objective on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Finally, Needham & Company LLC reissued a “hold” rating on shares of CVS Health Corporation in a report on Sunday, September 10th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $89.68.

ILLEGAL ACTIVITY NOTICE: This story was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://ledgergazette.com/2017/10/20/cvs-health-corporation-cvs-shares-sold-by-blue-fin-capital-inc.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmac

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Gemmer Asset Management LLC grew its holdings in CVS Health Corporation by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the last quarter. TB Alternative Assets Ltd. acquired a new stake in CVS Health Corporation in the 2nd quarter valued at approximately $121,000. SRS Capital Advisors Inc. grew its holdings in CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares during the last quarter. Grace & White Inc. NY acquired a new stake in CVS Health Corporation in the 2nd quarter valued at approximately $199,000. Finally, Nadler Financial Group Inc. acquired a new stake in CVS Health Corporation in the 2nd quarter valued at approximately $202,000. 81.46% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Corporation (NYSE:CVS) opened at 74.63 on Friday. The company has a market cap of $75.87 billion, a P/E ratio of 14.87 and a beta of 0.92. The company’s 50 day moving average price is $78.89 and its 200 day moving average price is $78.72. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $88.84.

CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same period in the prior year, the company earned $1.32 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts anticipate that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.68%. The ex-dividend date of this dividend is Monday, October 23rd. CVS Health Corporation’s payout ratio is presently 39.92%.

In other CVS Health Corporation news, CFO David M. Denton sold 237,078 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the completion of the sale, the chief financial officer now directly owns 141,096 shares in the company, valued at $11,238,296.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The disclosure for this sale can be found here. Insiders have sold 716,625 shares of company stock valued at $58,318,431 over the last 90 days. Corporate insiders own 0.61% of the company’s stock.

CVS has been the topic of a number of research analyst reports. BidaskClub lowered CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Loop Capital assumed coverage on CVS Health Corporation in a report on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective on the stock. Leerink Swann set a $90.00 price objective on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Finally, Needham & Company LLC reissued a “hold” rating on shares of CVS Health Corporation in a report on Sunday, September 10th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $89.68.

ILLEGAL ACTIVITY NOTICE: This story was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://ledgergazette.com/2017/10/20/cvs-health-corporation-cvs-shares-sold-by-blue-fin-capital-inc.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply